阿纳莫林是什么药？

A new, oral, selective ghrelin receptor agonist can improve weight loss and loss of appetite in patients with cancer cachexia. Anamorelin is the first drug to treat cancer cachexia. Today let’s take a closer look at what kind of medicine is Anamorelin?

Anamorelin will be launched in Japan in 2021 and is used to treat cancer cachexia in patients with gastric cancer, pancreatic cancer, non-small cell lung cancer, colorectal cancer and other malignant tumors. Anamorelin is produced and developed by Ono Pharmaceuticals and has exclusive rights to develop and commercialize it in Japan, South Korea, and Taiwan.

Cancer cachexia is a complex metabolic disorder syndrome that has a great adverse impact on patients' quality of life and prognosis. Clinical data show that anamorelin helps improve the quality of life of patients with cancer cachexia and has the effect of increasing body weight, muscle mass, and appetite.

Riccardo Braglia, CEO of Helsinn Group, said: "Two large clinical studies have shown that Anamorelin may enable patients to receive more treatments and increase their lean body mass. At the same time, Anamorelin can also reduce their symptoms and psychological stress, thereby improving their quality of life."

At present, this drug is not available in mainland China. Patients cannot buy this drug in hospital pharmacies. Patients in need can go to Japan or Taiwan to buy medicine, or they can get Anamorelin through medical companion travel. It is cost-effective. You only need to consult the medical companion travel service staff online about the drug purchase process and cost. Medical Travel is a relatively professional overseas medical service organization that can help patients obtain genuine drugs.

: Increased glycosylated hemoglobin and increased γ-GTP (serum γ-glutamyl transpeptidase). However, this drug also has some serious side effects, including: liver dysfunction, which sometimes occurs with increases in AST (aspartate aminotransferase), ALP (alkaline phosphatase), γ-GTP (serum γ-glutamyl transpeptidase), ALT (alanine aminotransferase), and blood bilirubin. Patients may also experience hyperglycemia and worsening of diabetes, and should pay attention to symptoms such as thirst and frequent urination. In addition, this drug sometimes causes patients to experience upper ventricular extrasystoles, atrioventricular block, bradycardia, palpitations, tachycardia, decreased blood pressure, etc.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: